Literature DB >> 15172235

Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter.

Shunsuke Yamada1, Tadasu Kohno.   

Abstract

BACKGROUND: Small, well-circumscribed pure ground-glass opacities on high-resolution computed tomography can represent either localized bronchioloalveolar carcinoma without foci of active fibroblastic proliferation, or atypical adenomatous hyperplasia. Since neither lesion displays lymph node metastasis, excellent prognosis can be expected even with limited surgical resection. In this study, video-assisted thoracic surgery was performed for patients with pure ground-glass-opacity to evaluate efficacy for both diagnostic and therapeutic purposes.
METHODS: Thirty-nine patients with pure ground-glass opacity less than or equal to 2 cm in diameter (62 lesions) underwent video-assisted thoracic surgery with wedge resection as primary therapy. Histologic diagnoses were made according to Noguchi classifications.
RESULTS: Single lesions were observed in 30 patients, with multiple lesions (mean, 4 lesions) in 9 patients. Twenty-eight patients underwent wedge resection. Seven patients underwent lobectomy or segmentectomy for technical reasons. Four patients underwent conversion of wedge resection to lobectomy (due to active fibroblastic proliferation in 2 patients, and other reasons in 2 patients). All procedures were performed under videoscopic observation. Histologic diagnoses comprised localized bronchioloalveolar carcinoma without active fibroblastic proliferation either alone or in combination with atypical adenomatous hyperplasia in 29 patients, atypical adenomatous hyperplasia in 8 patients, and localized bronchioloalveolar carcinoma with active fibroblastic proliferation in 2 patients. All patients with localized bronchioloalveolar carcinoma underwent follow-up for a median period of 29.3 months, and have survived without sign of recurrence.
CONCLUSIONS: Video-assisted thoracic surgery may be appropriate for management of small pure ground-glass opacities.

Entities:  

Mesh:

Year:  2004        PMID: 15172235     DOI: 10.1016/j.athoracsur.2003.12.040

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Radiologic and nuclear medicine predictors of tumor invasiveness in patients with clinical stage IA lung adenocarcinoma.

Authors:  Masaya Tamura; Makoto Oda; Isao Matsumoto; Yosuke Shimizu; Ryuichi Waseda; Go Watanabe
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

2.  Ground-glass opacities showing an adenoma-to-carcinoma sequence in the lung.

Authors:  Haruhiko Nakamura; Takeshi Hirata; Masahiko Taguchi; Hajime Kitamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-08-13

Review 3.  Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Authors:  Yoshihisa Kobayashi; Tetsuya Mitsudomi
Journal:  Transl Lung Cancer Res       Date:  2013-10

4.  Strategy of intentional limited resection for lung adenocarcinoma in situ.

Authors:  Terumoto Koike; Teruaki Koike; Masaya Nakamura; Yuki Shimizu; Tatsuya Goto; Seijiro Sato; Masanori Tsuchida
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 5.  Reclassification of early stage pulmonary adenocarcinoma and its consequences.

Authors:  Annikka Weissferdt; Cesar A Moran
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 6.  Emerging treatment options in the management of non-small cell lung cancer.

Authors:  Pier Luigi Filosso; Alberto Sandri; Alberto Oliaro; Andrea Riccardo Filippi; Maria Carla Cassinis; Umberto Ricardi; Paolo Olivo Lausi; Sofia Asioli; Enrico Ruffini
Journal:  Lung Cancer (Auckl)       Date:  2011-06-08

7.  Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.

Authors:  Long Jiang; Weiqiang Yin; Guilin Peng; Wei Wang; Jianrong Zhang; Yang Liu; Shengyi Zhong; Qihua He; Wenhua Liang; Jianxing He
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

Review 8.  Small peripheral lung adenocarcinoma: clinicopathological features and surgical treatment.

Authors:  Takayuki Fukui; Tetsuya Mitsudomi
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

Review 9.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

10.  Outcomes: wedge resection versus lobectomy for non-small cell lung cancer at the Cancer Centre of Southeastern Ontario 1998-2009.

Authors:  Anna L McGuire; Wilma M Hopman; Dimitri Petsikas; Ken Reid
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.